ANXIETY is the #6 most commonly reported adverse reaction for ARIPIPRAZOLE ORAL, manufactured by Accord Healthcare, Inc.. There are 1,681 FDA adverse event reports linking ARIPIPRAZOLE ORAL to ANXIETY. This represents approximately 2.1% of all 79,930 adverse event reports for this drug.
Patients taking ARIPIPRAZOLE ORAL who experience anxiety should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
ANXIETY1,681 of 79,930 reports
ANXIETY is a less commonly reported adverse event for ARIPIPRAZOLE ORAL, but still significant enough to appear in the safety profile.
Other Side Effects of ARIPIPRAZOLE ORAL
In addition to anxiety, the following adverse reactions have been reported for ARIPIPRAZOLE ORAL:
ANXIETY has been reported as an adverse event in 1,681 FDA reports for ARIPIPRAZOLE ORAL. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is ANXIETY with ARIPIPRAZOLE ORAL?
ANXIETY accounts for approximately 2.1% of all adverse event reports for ARIPIPRAZOLE ORAL, making it a notable side effect.
What should I do if I experience ANXIETY while taking ARIPIPRAZOLE ORAL?
If you experience anxiety while taking ARIPIPRAZOLE ORAL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.